Additionally, under the terms of agreement, ITI Limited has already received the first tranche of ₹100 Crore from C-DoT on February 19, 2025.

Axis Securities and JM Financial both maintain 'Buy' ratings on Biocon, with target prices of Rs 370 and Rs 380, respectively. Biocon has a strong product pipeline, including new offerings expected to ...

ITI Ltd., incorporated in the year 1950, is a Mid Cap company (having a market cap of Rs 25,867.08 Crore) operating in Telecommunications sector. ITI Ltd. key Products/Revenue Segments include Sale of ...